treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...
: 00004024 CLINICAL NURSE II Job Level: F2 Duke is an Equal Opportunity Employer committed to providing employment opportunity..., national origin, race, religion, sex (including pregnancy and pregnancy related conditions), sexual orientation or military...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., color, religion, sex gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., including: Patient-level data (APLD): IQVIA, Komodo, PurpleLab, etc. Formulary data: MMIT Projected national data: Xponent, NSP...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...
) and other regulatory requirements Pre-employment Physical Capacity Testing Required Job Code: 00004024 CLINICAL NURSE II Job Level: F2..., color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...